The PDF brochure for the 5th Annual Rare Disease Market Access & Commercialization Summit is now available. Download it now

Featured Speakers

Top Reasons to Attend:

  • Hear directly from leading manufacturers incuding: Merck, GSK, Bayer, Roche, Amgen and many more..
  • Exchange best practices for overhauling market access strategies in a value-based healthcare landscape and maximize the yield potential of the $100 billion rare disease drug market
  • Participate in two intensive workshops on: The Establishment of Expanded Access Programs and Mapping the Patient Journey for Greater Insights and Targeted Commercial Strategies
  • Network with market access and commercialization colleagues across Oncology, Cell and Gene, and Biosimilars for industry wide plenary sessions
  • Gain insights to ensure your Payer interactions and value proposition meets external stakeholder demands

Deep Dive and Get into the Weeds with our Hands-on Workshops

  1. Launch an Expanded Access Program that Effectively Supports Patient Needs and Compliantly Enhances Drug Development
  2. Map the Patient Journey to Enhance Rare Disease Drug Commercialization and Post-Market Surveillance
  3. Explore Specialty Pharmacy Delivery Models in an Increasingly Complex Healthcare System

Lead Sponsor